The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gondré-Lewis, T. A.
Right arrow Articles by Drake, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gondré-Lewis, T. A.
Right arrow Articles by Drake, J. R.
The Journal of Immunology, 2001, 166: 6657-6664.
Copyright © 2001 by The American Association of Immunologists

Prolonged Antigen Persistence Within Nonterminal Late Endocytic Compartments of Antigen-Specific B Lymphocytes1

Timothy A. Gondré-Lewis2, Amy E. Moquin and James R. Drake3

Trudeau Institute, Saranac Lake, NY 12983

Although Ag-specific B lymphocytes can process Ag and express peptide-class II complexes as little as 1 h after Ag exposure, it requires 3–5 days for the immune system to develop a population of Ag-specific effector CD4 T lymphocytes to interact with these complexes. Presently, it is unclear how B cells maintain the expression of cell surface antigenic peptide-class II complexes until effector CD4 T lymphocytes become available. Therefore, we investigated B cell receptor (BCR)-mediated Ag processing and presentation by normal B lymphocytes to determine whether these cells have a mechanism to prolong the cell surface expression of peptide-class II complexes derived from the processing of cognate Ag. Interestingly, after transit of early endocytic compartments, internalized Ag-BCR complexes are delivered to nonterminal late endosomes where they persist for a prolonged period of time. In contrast, Ags internalized via fluid phase endocytosis are rapidly delivered to terminal lysosomes and degraded. Moreover, persisting Ag-BCR complexes within nonterminal late endosomes exhibit a higher degree of colocalization with the class II chaperone HLA-DM/H2-M than with the HLA-DM/H2-M regulator HLA-DO/H2-O. Finally, B cells harboring persistent Ag-BCR complexes exhibit prolonged cell surface expression of antigenic peptide-class II complexes. These results demonstrate that B lymphocytes possess a mechanism for prolonging the intracellular persistence of Ag-BCR complexes within nonterminal late endosomes and suggest that this intracellular Ag persistence allows for the prolonged cell surface expression of peptide-class II complexes derived from the processing of specific Ag.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. L. Fallas, W. Yi, N. A. Draghi, H. M. O'Rourke, and L. K. Denzin
Expression Patterns of H2-O in Mouse B Cells and Dendritic Cells Correlate with Cell Function
J. Immunol., February 1, 2007; 178(3): 1488 - 1497.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Drake, E. M. McGovern-Brindisi, and J. R. Drake
BCR ubiquitination controls BCR-mediated antigen processing and presentation
Blood, December 15, 2006; 108(13): 4086 - 4093.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. O. Nashar and J. R. Drake
The Pathway of Antigen Uptake and Processing Dictates MHC Class II-Mediated B Cell Survival and Activation
J. Immunol., February 1, 2005; 174(3): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Putnam, A. E. Moquin, M. Merrihew, C. Outcalt, E. Sorge, A. Caballero, T. A. Gondre-Lewis, and J. R. Drake
Lipid Raft-Independent B Cell Receptor-Mediated Antigen Internalization and Intracellular Trafficking
J. Immunol., January 15, 2003; 170(2): 905 - 912.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Chen, O. Laur, T. Kambayashi, S. Li, R. A. Bray, D. A. Weber, L. Karlsson, and P. E. Jensen
Regulated Expression of Human Histocompatibility Leukocyte Antigen (HLA)-DO During Antigen-dependent and Antigen-independent Phases of B Cell Development
J. Exp. Med., April 15, 2002; 195(8): 1053 - 1062.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.